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Restoring the Final Frontier: 
Exosomal MicroRNA and 
Cutaneous Wound Repair
Iain Dykes, Kehinde Ross
School of Pharmacy and Biomolecular Science, Liverpool John Moores University, Liverpool, United Kingdom.
Non-healing wounds present a major healthcare challenge associated with the ageing population, the rising inci-
dence of diabetes and the obesity epidermic. Driven by the need to expand therapeutic options for the treatment 
of such wounds, a large body of evidence has emerged in recent years demonstrating that microRNAs (miRNAs) 
modulate various aspects of cutaneous wound healing through effects on diverse cell types, including keratinocytes, 
fibroblasts, endothelial cells and macrophages. However, clear translational pathways for non-invasive cutaneous 
delivery of miRNAs to facilitate wound repair have not yet been established. The recognition that miRNAs can be 
actively partitioned into extracellular vesicles (EVs)—exosomes, microvesicles and apoptotic bodies—has stimulated 
research into the regulation, function and translational exploitation of EV-derived miRNAs both as a novel mode of 
intercellular signalling and as a tool for miRNA transfer to cells for therapeutic purposes. In particular, because mes-
enchymal stem cells (MSCs) were found to support wound healing, there is much interest in the therapeutic potential 
of EVs, especially exosomes, derived from these cells. In this review, we survey some of the main mesenchymal stem 
cells (MSCs) for which exosomal miRNAs have been evaluated in the context of skin repair, including exosomes from 
adipose-derived MSCs, bone MSCs, amniotic MSCs and umbilical cord MSCs. Epithelial stem cell (EPSC)-derived 
exosomes are also considered, from keratinocytes and epidermal stem cells. The picture that emerges from studies 
on exosomes from various cell types reveal they share a limited set of exosomal miRNAs enhancing wound repair. 
We suggest a need for direct comparison of exosomal miRNA profiles from a range of MSCs and EPSCs. The ability 
of exogenous exosomal miRNAs to promote healing of chronic diabetic wounds also warrants further attention in 
order to more fully establish their therapeutic potential.
stages comprising inflammation, proliferation, 
angiogenesis, epithelialisation and remodelling [7-10]. 
Despite healing rates of only 30 to 56% there are only 
four approved therapies for chronic cutaneous wounds 
to date [11]. Hence, there is a clear need to develop 
additional therapies with improved efficacy. 
A large body of evidence has emerged showing small 
non-coding RNAs of the microRNA (miRNA) family 
enhance diverse aspects of wound healing [12-22] while 
other miRNAs exert an inhibitory role [23-34]. However, 
these knowledge gains have not translated into patient 
benefit and only 3 trials relevant to cutaneous wound 
repair were returned in a search of the ClinicalTrial.gov 
database (condition or disease: microRNA; other terms: 
wound healing; searched 30th April 2021. NCT02024243; 
NCT03601052 NCT03603431). Further, the most efficient 
mechanisms for delivery of miRNA mimics or inhibitors 
to target cells to promote wound repair have not been 
established. 
Extracellular vesicles (EVs), comprising exosomes 
(EXOs), microvesicles (MVs) and apoptotic bodies 
(ABs), have emerged as novel mediators of intercellular 
communication [35-37]. In particular, because EVs carry 
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INTRODUCTION
Chronic wounds have emerged as a major public 
health challenge associated with enormous negative 
implications on quality of life and healthcare budgets [1, 
2]. Much of the increased prevalence of chronic wounds 
including foot ulcers, pressure ulcers, venous ulcers 
and other non-healing wounds stems from the ageing 
population, the elevated incidence of diabetes and the 
obesity epidemic [1, 3].  Early estimates put the costs of 
managing chronic wounds in the UK at £5.3 billion annually 
[4] and $25 billion per year in the USA [5]. However, a 
recent assessment based on Medicare expenditures 
related to wound care spanning various ulcers, surgical 
wounds, traumatic wounds and, respectively, associated 
infections, estimated the total cost ranged from $28.1 
billion at the lower end to $96.8 billion at the upper limit 
[6].  
Cutaneous wound healing is a complex physiological 
process that helps preserve the integrity of the organism 
by restoring the skin barrier. This process is mediated by 
extensive cross-talk between diverse cell types including 
keratinocytes, fibroblasts, endothelial cells and immune 
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diverse molecular cargoes, including miRNA, RNA, DNA, 
proteins and metabolites and given that miRNAs regulate 
wound repair, there is great interest in understanding 
and exploiting exosomal miRNA to enhance wound 
repair. In this review, we summarise the mechanisms 
of miRNA biogenesis and introduce EVs in some detail, 
with a focus on EXOs. We then review recent insights 
in relation to the deployment of EXOs and other EVs 
from various mesenchymal and epithelial stem cells 
to promote wound repair in the skin. Circulating blood-
based EXOs are not considered within the scope of the 
present work.
MICRORNA BIOGENESIS AND FUNCTION: A BRIEF 
OVERVIEW 
MicroRNAs (miRNA) are small regulatory RNA 
Figure 1: miRNA Biogenesis 
miRNA may be produced through a canonical or a non-canonical pathway. In the canonical pathway miRNA genes, 
which often contain clusters of miRNAs, are transcribed by RNA Pol II  to produce a primary miRNA transcript (pri-miR). 
This is then processed by a complex containing DROSHA and DGCR8 to yield a pre-miR consisting of a single 60-70nt 
stem-loop structure. In the non-canonical pathway, miRNA are encoded within the introns of mRNA and are processed 
by the spliceosome to produce a pre-miR. The pre-miR is exported to the cytoplasm by XPO5. Here, it is processed by 
DICER to produce a 21-nt double stranded RNA. One or both of these strands will then associate with AGO2 to form 
the mRNA-targeting RISC complex.
molecules that silence gene expression by post-
transcriptional mechanisms that culminate in 
destabilisation and degradation of their messenger 
RNA targets [38, 39]. Canonical miRNAs are generated 
through a well-established mechanism that involves 
transcription of diverse genomic loci to yield a primary 
transcript that can be thousands of base pairs long [40-
42]. These pri-miRNAs fold into a hairpin structure that 
is cleaved by a complex of DROSHA and DGCR8, also 
known as the Microprocessor  [43], for which structural 
mechanisms have recently been established [44]. The 
resulting precursor miRNAs (pre-miRNAs) are exported 
from the nucleus predominantly but not exclusively by 
the exportin 5 (XPO5) complex [45, 46]. In the cytoplasm, 
the loop region of the pre-miRNA hairpin is cleaved by 
DICER complex leaving the duplex of the 5 prime and 
Biomolecular Research ReportsReview
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these into ILVs [63]. ESCRT-independent pathways also 
exist, such as those involving the tetraspanin CD63 [64], 
which is also the most reliable membrane epitope used 
to identify EXOs [62], CD81 and CD9 being also present 
in subsets of EXOs.
Microvesicles (MVs) were first described in platelets [65] 
and they are best characterised as products of various 
blood cell types. Other names used for MVs include 
shedding vesicles, microparticles and ectosomes. 
Microvesicles are produced by budding directly from the 
plasma membrane and do not arise from an intracellular 
precursor, but much less is known about their synthesis 
compared to EXOs. Annexin A1 is a unique marker 
for microvesicles [62]. A role in cell signalling was 
demonstrated when it was shown that MVs mediate 
horizontal transfer of a truncated, oncogenic form of 
the epidermal growth factor receptor (EGFR) between 
neighbouring cells [66]. 
Purification of EVs is normally achieved based on 
size. In a standard protocol a series of centrifugations 
of increasing speed is used to remove larger particles, 
before ultracentrifugation at 100,000g is used to pellet 
the smallest EVs [67]. Size exclusion chromatography 
is also increasingly being used. In practise it is very 
hard to obtain a pure population of one class or the 
other due to overlapping size and epitope expression 
and most published studies are probably describing a 
heterogeneous population of EVs. Furthermore, this 
classification may be over-simplistic and additional 
classes have since been described. For these reasons, 
current recommendations from the International Society 
for Extracellular Vesicles (ISEV) [68] suggest providing 
quantitative details on isolation methods such as 
3 prime (-5p) and (-3p) arms. Non-canonical miRNA 
biogenesis occurs through multiple mechanisms [47], 
including a DROSHA-independent approach in which 
“mirtrons” are spliced out of introns and de-branched to 
yield a pre-miRNA [48] and a mechanism for miR-451 
which depends on DROSHA but not DICER [49].  
One strand of the mature duplex is loaded into the 
argonaute (AGO) protein to form the RNA-induced 
silencing complex (RISC). This “guide” strand directs 
the AGO to the 3’UTR of target mRNA transcripts, while 
the “passenger” strand is unwound and largely degraded 
(Figure 1). The guide and passenger strands were 
initially distinguished as miR and miR*, respectively. 
However, evidence soon emerged indicating the so-
called passenger strands can persist, bind AGO and 
mediate gene silencing [50-53]. Therefore miRNAs are 
increasingly designated with -5p or  -3p to indicate which 
arm of the duplex they arise from, although this approach 
fails to distinguish the dominant major strand from the 
less dominant or minor strand, as others have observed 
[54]. 
The choice of guide or passenger strand depends on 
the identity of the 5′ nucleotide of each strand and relative 
thermodynamic stability of the ends of the duplex [55-
57], reviewed in [54]. The strand with its 5′ terminus at 
the end of the duplex with lower thermodynamic stability 
is preferentially loaded into AGO as the guide strand, 
with a preference for 5′ terminal UMP>AMP>CMP>GMP 
[56]. However, careful analysis across C. elegans, D. 
melanogaster and H. sapiens suggests that only half of 
miRNAs follow one or other of these rules, and ~20% do 
not follow either rule, indicating that there is complexity 
in the control of strand selection that has not yet been 
uncovered [54]. 
EXTRACELLULAR VESICLES: A BRIEF PRIMER 
The classification of EVs into three classes EXOs, MVs 
and ABs reflects differences in their biogenesis (Figure 
2). Exosomes are derived from the endosomal pathway 
and are the smallest of the three, with a size range of 
40-150 nm [58-60]. Microvesicles overlap with EXOs at 
the lower end of their size range, ~100 nm in diameter 
[61], but can also be much larger, with an average 
reported upper end of 350 nm [61] with some reports up 
to approximately 1 μm [62]. Apoptotic bodies (ABs) are 
produced by cellular breakdown during apoptosis and 
are the largest class, being 1-5 µm [62].  
The first step in EXO biogenesis is endocytosis of the 
plasma membrane to form an endosome. Invaginations 
of the endosome membrane result in the formation of 
intraluminal vesicles (ILVs) within a structure called 
the mutlivesicular body (MVB). The MVB can either 
be targeted to the lysosome for degradation of vesicle 
contents or can fuse with the plasma membrane to 
release EXOs. The proteins which regulate these 
processes are shared with other intracellular trafficking 
pathways, and as a result, very few unique markers 
for exosomes exist. The endosomal sorting complex 
required for transport (ESCRT) regulates MVB formation, 
recognising ubiquitinated membrane proteins and sorting 
Figure 2: Biogenesis of exosomes, microvesicles 
and apoptotic bodies
Although overlapping in size and sharing expression 
of many miR and protein, microvesicles and exosomes 
are derived by different mechanisms. Microvesicles are 
derived by budding directly from the plasma membrane. 
Exosomes are derived from the endosomal pathway. 
Endocytosis results in formation of an endosome. 
Invagination of the endosome membrane results in 
formation of intraluminal vesicles within a multivesicular 
body (MVB). Fusion of the MVB with the plasma 
membrane releases exosomes. Apoptotic bodies, which 
are much larger than the other classes, are derived by 
blebbing from dying cells.
Biomolecular Research ReportsReview
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appear to be shared with other classes of EV [69]. 
Larger MVs (defined in this study as particles pelleting 
at 25,000g but not at 3000g) from keratinocytes have 
been shown to transfer miR-21-5p to fibroblasts [73], as 
discussed below.
MECHANISMS of microRNA LOADING 
A selective mechanism exists to load miRNA into EVs 
(Figure 3). This can be seen, for example, in analysis 
of activation-induced changes in miRNA expression 
in T lymphocytes and their EVs which demonstrated 
that miRNA expression changes in secreted EVs are 
not the same as changes in the cells themselves [74]. 
Therefore, the EV miRNA population is not simply a 
snapshot of miRNA present in the parental cell, but rather 
is specifically trafficked to these structures.
Several mechanisms underpinning selective miRNA 
loading into EVs have been demonstrated, and it seems 
that there may be more than one way to achieve this. It 
is also possible that passive loading occurs in addition to 
active mechanisms. Naked miRNA is quickly degraded 
by RNases present within the cell, and therefore all 
stable miRNA must be associated with protein [70]. It is 
these RNA-binding proteins, or proteins that interact with 
them, that regulate trafficking.
centrifugal force used. ISEV recommend using the 
general term extracellular vesicle (EV) for all particles 
and describing them by physical characteristics such as 
size (the terms small EV, medium EV and large EV may 
be appropriate) or epitope expression [68].
All three classes of EVs have been shown to carry RNA 
and to deliver this to target cells. The miRNA cargo of 
EXOs appears to be distinct from that of ABs and MVs, 
which are more similar [69]. The presence or otherwise of 
other nucleic acids within EVs is more controversial. For 
example, DNA fragments greater than 3 kb and ribosomal 
RNA can be eluted with EVs from size exclusion columns 
or co-precipitated by ultracentrifugation making it difficult 
to confirm the source of these molecules [70]. 
Interestingly, cells undergoing apoptosis are able to use 
ABs in order to signal to their neighbours. These vesicles 
can be taken up by target cells [71]. For example, in 
atherosclerosis vascular endothelial cells release ABs 
which carry miR-126 [72]. miR-126was delivered to 
neighbouring cells where it inhibits the negative regulator 
RGS16, leading to production the chemokine CXCL12, 
recruiting progenitor cells for repair [72]. Next generation 
sequencing of primary human keratinocytes identified 
608 miRNAs present in ABs (for this study, defined as 
particles pelleting at 3000g), of which about two thirds 
Figure 3: Potential mechanisms of miRNA trafficking into exosomes
a. Two of the best described mechanism involve a sequence-directed mechanism by which the ribonucleoprotein 
hnRNPA2B1 recognises an EV trafficking motif within the miR and a general mechanism by which proteins such as 
TNRC6 interact with both the RISC complex (represented here by AGO2) and the ESCRT complex within the MVB 
membrane. b. miR-601 is an example of a miRNA containing a cis-acting trafficking motif located towards the 3′ end. 
The mRNA target recognition motif is located at the 5′ end.
Biomolecular Research ReportsReview
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YBX1, has also been shown to play a role in miRNA 
loading into EVs [81]. Interestingly, Argonaute proteins 
have been reported to be absent in EXOs by many 
studies [62, 79, 81], indicating that the RISC must be 
disassembled as miRNA are trafficked into EXOs. 
RNA editing is another potential regulatory mechanism. 
There is evidence that miRNAs sometimes contain 
non-template-encoded nucleotides and this may be 
a mechanism for sorting. In one study, 3′ adenylation 
was associated with cellular miRNA while 3′ uridylation 
seemed to label miRNAs enriched in EVs [82].
MESENCHYMAL STEM CELL-DERIVED EXOSOMES
Exosomes from various sources have proved to be a 
rich source of miRNAs that can facilitate wound closure 
but work on mesenchymal stem cells (MSC)-derived 
exosomes (MSC-EXO) has outpaced work on epithelial 
stem cell exosomes (EPSC-EXO). Major sources of 
MSCs include adipose tissue, bone marrow, synovium, 
placenta and umbilical cord [83], and their translational 
utility in wound repair stems from studies showing 
MSC differentiation into various cell types required for 
tissue regeneration in wounded skin. For instance, 
Specific trafficking of miRNA subsets may be regulated by 
a cis-acting sequence motif, recognised by RNA-binding 
proteins somewhat analogous to the Zipcode binding 
proteins of mRNA [75]. Short motifs have been identified 
within populations of EV enriched mRNA [76]. The 
heterogeneous nuclear ribonucleoproteins (hnRNPs) 
appear to be involved in trafficking of both mRNA and 
miRNA [74]. hnRNPA2B1 recognises a 21-nt sequence 
called RNA trafficking sequence (RTS) in neuronal 
trafficked mRNA [77], whereas an element of this same 
sequence, a shorter 4-nt motif, is present in the 3′ half 
of miRNA trafficked into T-cell EXOs [74]. Thus, miRNA 
have a cis-acting sequence motif located adjacent to the 
5′ target-binding seed sequence. It is worth noting that 
trafficking of mRNA may be regulated through differential 
splicing to alter the 3′ UTR [78] whereas miRNA are not 
spliced, therefore any targeting motif present within a 
miRNA will always direct trafficking if the relevant RNA-
binding protein is present.
Interestingly, TNRC6 (also known as GW182), which 
interacts with Argonautes in processing (P) bodies, also 
appears to interact with the ESCRT complex on MVBs to 
load miRNA into EXOs [79, 80]. Another P-body protein, 
TABLE 1: Selection of exosomal microRNAs associated with wound healing
Source of exosomes MicroRNA Target cells examined Supporting animal work Reference






diabetic rat wounds [93]
BMSC miR-126-3p HUVEC Streptozotocin-induced diabetic rat wounds [96]
hAMSCs miR-135a-5p BJ human fibroblast cell line Wounded rat skin [106]
hAECs
Small RNAs 
implicated but not 
defined
HDF Wounded mouse skin [108]
ucMSC miR-21-5p HDF Wounded mouse skin [112]
UCB miR-21-3p HDFHMEC Wounded mouse skin [116]
Human keratinocytes  









knockout mice [119, 120]
Human epidermal stem 
cells
miR-425-5p miR-
142-3p HDF Wounded rat skin [127]
ADSC, adipose-derived stem cells; hAMSC, human amniotic mesenchymal stem cells; hAECs, human amniotic 
epithelial cells; BMSC, bone mesenchymal stem cells; HDF, human dermal fibroblasts; HMEC, human microvascular 
endothelial cells; HUVECs, human umbilical vein endothelial cells; ucMSC, umbilical cord-derived mesenchymal stem 
cells; UCB, umbilical cord blood.
*Protocols used were aimed at capturing microvesicles rather than exosomes
Biomolecular Research ReportsReview
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and blood vessel maturation when applied topically to a 
rat diabetic wound model, thus enhancing wound closure 
[93]. Mechanistically, the effects of the engineered 
ADSC-Exos were associated with elevated expression of 
β-catenin, Wnt4 and MMP-7 in HaCaT keratinocytes [93]. 
However, the targets directly repressed by miR-21-5p to 
thus modulate the β-catenin, Wnt4 and MMP-7 axis were 
not defined nor were the mechanisms by which ADSC-
Exos-miR-21-5p promotes angiogenesis explored. More 
importantly, head-to-head comparisons of ADSC-Exos-
miR-21-5p loaded with other pro-healing miRNAs such 
as miR-31-5p, miR-132-3p, miR-129-5p and miR-335-
5p, which have recently been reviewed [94], would help 
establish the relative potencies of ADSC-EXOs loaded 
with each of these miRNAs. 
Bone Mesenchymal Stem Cells: hypoxic 
enhancement of exosome performance 
Bone Mesenchymal Stem Cells (BMSCs) are non-
haematopoietic multipotent stem cells derived from the 
bone marrow, and can differentiate into osteoblasts, 
chondrocytes, and adipocytes. Perhaps surprisingly, 
there is evidence that EXOs from BMSCs can stimulate 
proliferation of HaCaT keratinocytes and dermal 
fibroblasts, though a role for miRNA was not established 
in that work [95].
Recent studies have also shown that BMSC-derived 
EXOs can enhance the angiogenic behaviour of human 
umbilical vein endothelial cells (HUVECs), and accelerate 
cutaneous wound closure in diabetic rats [96]. Further, 
the authors examined the impact of hypoxia on BMSC-
EXOs function, given that hypoxia plays keys roles in 
wound healing and can boost the ability of ADSC-EXOs 
to promote angiogenesis [97, 98]. Hypoxic BMSC-EXOs 
out-performed normoxic counterparts in relation to both 
angiogenesis by HUVECs and wound healing in diabetic 
rats [96]. Crucially, the pro-angiogenic miRNA miR-126-
3p was elevated ~5-fold in EXOs from hypoxic BMSCs, 
and inhibition of miR-126-3p in HUVECs abrogated 
the proangiogenic impact of hypoxic BMSC-EXOs, 
consistent with the known roles of miR-126,  [96, 99]. 
Elevation of exosomal miR-126-3p by direct transfection 
of BMSCs has also very recently been shown to enhance 
angiogenesis, and wound closure in mouse skin was 
thus accelerated [100].
Together, the above studies suggest that BMSC-
derived EXOs can be exploited to accelerate cutaneous 
wound healing and elevation of miR-126-3p in such 
EXOs drives an angiogenic program to support wound 
repair. Questions remain, however, concerning the full 
spectrum of exosomal miRNAs from hypoxic BMSCs 
and whether the same cohort of exosomal miRNAs are 
consistently elevated by hypoxia treatment of diverse 
MSCs. The impact of hypoxia on the generation and 
function of exosomal miRNA for cutaneous wound 
healing has received limited attention, despite the 
prominence hypoxia-induced EVs have gained over the 
last decade [101]. 
Human Amniotic Mesenchymal Stem Cell Exosomes: 
exploiting placental cells for wound repair 
adipose-derived stem cells (ADSCs) differentiate into 
keratinocytes, fibroblasts and endothelial cells [84], 
while  bone-marrow derived MSC (BMSC) differentiated 
into keratinocytes, endothelial cells and monocytes [85]. 
However, the limited persistence of MSCs in damaged 
tissue, with less than 1% of such cells remaining in 
the damaged tissue after 1 week, combined with the 
observation that conditioned media from MSC cultures 
have regenerative capacities that match or even exceed 
those of their parent cells has led to the notion that EVs 
rather than MSCs themselves are the main drivers of 
MSC-mediated wound repair [83]. We assess the use 
of EVs from these tissues to promote wound repair in 
a miRNA-dependent manner as summarised in Table 1.
Adipose-derived Mesenchymal Stem Cell Exosomes: 
fat cell functions beyond fat 
Adipose-derived stem cells (ADSCs) are multipotent 
stem cells derived from the stromal vascular fraction 
of subcutaneous adipose tissue [86]. These cells are 
attractive for regenerative medicine due to their relative 
ease of isolation. The ability of ADSCs and EXOs thereof 
to promote wound healing has gained substantial support 
in recent years [84, 87-89].  In excisional mouse wounds, 
the ADSC-EXOs boosted wound closure, whether 
delivered by local injection or intravenous administration 
[90, 91]. Elevated miR-21-5p was detected at the 
wound edge after application, though the precise cells 
in which miR-21-5p was raised compared to controls 
were not defined [91]. Conceivably both fibroblasts and 
keratinocytes are target cells for ADSC-EXO miRNA 
applied to wounded skin, but the relative accumulation of 
ADSC-EXOs (or any other exosomes) and their miRNA 
cargoes into fibroblasts and keratinocytes when applied 
to (wounded) skin is unclear. Studies on cultured HDFs 
(human dermal fibroblasts) showed the ADSCs-EXOs 
were internalised by the cells, promoting migration, 
proliferation and collagen synthesis in a dose-dependent 
manner [90]. However, the miRNAs involved in these 
effects of ADSCs-EXOs on fibroblasts were not defined. 
There appears to be only limited evidence of essential 
roles for ADSC-EXOs miRNAs in fibroblasts at present. 
A recent screen identified 292 differentially expressed 
miRNAs in ADSC-EXOs compared to ADSC themselves 
and although important targets were predicted no 
experimental support was provided to confirm the 
functional significance of ADSC-EXO-derived miRNA on 
fibroblasts [92]. 
In contrast, ADSC and ADSC-EXOs promoted the 
migration and proliferation of HaCaT keratinocytes at 
least partly through miR-21-5p, and may involve miR-
21-5p-dependent silencing of transforming growth 
factor beta (TGF-β1) expression, elevation of matrix 
metalloproteinase-9 (MMP-9) and repression of tissue 
inhibitor of metalloproteinase-2 TIMP-2 [91]. Further 
studies also show enhancement of wound healing by 
ADSC-EXOs loaded with miR-21-5p mimic. These 
“engineered” ADSC-EXOs promoted HaCaT keratinocyte 
proliferation and migration compared to native ADSC-
EXOs and accelerated re-epithelialisation, angiogenesis 
Biomolecular Research ReportsReview
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the authors identified 10 miRNAs that were highly 
expressed in ucMSC-EXO. These miRNAs appeared 
to be actively partitioned into EXOs because, with the 
exception of miR-21-5p, their levels were relatively 
high in the ucMSC-EXOs compared to ucMSCs [112]. 
Moreover, none of the 10 miRNAs identified by Xing and 
colleagues were enriched in an independent microarray-
based assessment of miRNAs in EVs from ucMSC [113]. 
It is conceivable that the specific accumulation in EXOs 
is no longer detectable in such bulk EV analysis, lending 
credence to the notion of selective miRNA secretion into 
ucMSC-EXOs, though technical differences (RNAseq 
versus microarray) may be a confounding factor. 
Notably, miR-21-5p was the most abundant miRNA in 
both ucMSC and ucMSC-EXO [112]. More importantly, 
miR-21-5p, miR-23a-3p, miR-125b-5p, and miR-145-5p, 
were all predicted and shown to target genes associated 
with the TGF-β/SMAD2 pathway, such as TGF-β2, TGF-
βR2, and SMAD2. When transfected into HDFs, these 
miRNAs individually impaired TGFβ-induced activation 
of SMAD2 and expression of alpha smooth muscle actin 
(α-SMA), a hallmark of myofibroblast differentiation, 
[8]. On the other hand, early work had indicated that a 
miR-21-5p mimic boosted differentiation of (MRC-5) 
lung fibroblasts into myofibroblasts [114], and similar 
observations were recently reported in skin fibroblasts 
[115]. Hence it appears that while miR-21-5p can dampen 
TGFβ signalling to α-SMA induction, the main outcome 
in unstimulated fibroblasts transfected with miR-21-5p is 
the promotion of fibroblast:myofibroblast differentiation. 
Exosomes from umbilical cord blood (UCB) have also 
been evaluated [116]. Injection of UCB-EXOs accelerated 
re-epithelialisation, angiogenesis and wound closure, 
with reduced scarring [116]. Of a selection of miRNAs 
(miR-21, miR-214, miR-126, miR-27b, miR-125b and 
miR-19b, both 5p and 3p strands, respectively) miR-
21-3p was the most abundant in UCB-EXOs. The UCB-
EXOs were internalised by endothelial cells (ECs) and 
HDFs, promoting migration and proliferation of these 
cells in a miR-21-3p dependent manner [116]. The 
effects of miR-21-3p on HDF and ECs were attributed to 
silencing of PTEN and SPRY1 as treatment with UCB-
EXOs lead to depletion of these negative regulators of 
signalling and this was accompanied with enhanced 
activation of the Akt pro-survival and ERK1/2 mitogenic 
pathways [116]. Interestingly, very recent studies 
observed miR-21-3p was depleted in the serum of 
diabetes patients, in HDFs stimulated with high glucose 
and in the skin of db/db mice, where wounding further 
reduced miR-21-3p expression [117]. A miR-21-3p mimic 
enhanced HDF proliferation as well as collagen and 
growth factor expression and accelerated wound closure 
in mouse skin. Mechanistically, the effects of miR-21-3p 
were linked to direct repression of SPRY1 by miR-21-
3p [117]. Together, these findings on miR-21-3p function 
in exosomal and non-exosomal contexts suggest that 
earlier studies of miR-21 in wound repair using pre-
miR-21 or miR-21 mimic [12, 19] may reflect activity of 
both miR-21-5p and miR-21-3p. 
The amniotic membrane of the placenta has long been 
recognised as a source of multipotent stem cells that can 
be accessed with limited ethical constraints [102, 103]. 
Amniotic epithelial cells and amniotic mesenchymal cells 
have gained traction as multipotent cells that can be 
deployed in a wide range of applications [104]. Amniotic 
membrane and composites thereof have been deployed 
in a wide range of applications associated with the repair 
of cutaneous, ocular, oral, gastric and urinary defects 
[105]. Recent studies have implicated exosomal miRNAs 
from both human amniotic mesenchymal stem cells 
(hAMSC) and human amniotic epithelial cells (hAECs), 
in relation to wound healing. For instance, hAMSC and 
exosomes thereof promoted closure of rat wounds, 
the hAMSC exosomes boosted migration of a human 
fibroblast cell line [106]. Furthermore, miR-135a-5p was 
found to contribute to the effects of hAMSC exosomes 
on wound closure and fibroblast migration, particularly 
when overexpressed in the hAMSC prior to isolation of 
exosomes [106]. The pro-healing effects of miR-135a-
5p were linked to its ability to repress large tumour 
suppressor 2 (LATS2), a Ser/Thr kinase associated 
with the Hippo pathway [107]. It was not clear, however, 
whether miR-135a-3p, the partner strand from the 
pre-miR-135a duplex, was also loaded into hASMC 
exosomes. Feinberg and colleagues have shown that 
miR-135a-3p regulates wound closure, and inhibition 
of miR-135a-3p increased angiogenesis, granulation 
tissue formation wound repair in diabetic mouse wounds 
[32]. Therefore, it is important to determine whether 
the pro-healing potential of miR-135a-5p in hAMSCs 
exosomes is counterbalanced by putative miR-135a-3p 
contributions. 
Interestingly, human amniotic epithelial cells (hAECs) 
have also been found to possess small RNAs that can 
support fibroblast migration and accelerate wound 
closure in mice [108]. However, the specific miRNAs 
underpinning such pro-healing activity were not defined. 
We also do not know at present the relationships 
between hAEC and hAMSC exosomes in terms of the 
total amount of miRNAs per exosome and the specific 
miRNA profiles associated with each source.
Human Umbilical Cord Mesenchymal Stem Cell 
Exosomes: towards scar-free wound healing
The umbilical cord and umbilical cord blood provide 
MSCs with distinct miRNA profiles [109],and EXOs 
from both have been exploited to promote wound 
healing. Studies have shown that umbilical cord-
derived MSCs (ucMSCs) EXOs can impair the TGF-β 
signalling pathway and this appears to dampen fibroblast 
differentiation into myofibroblasts [110]. This is important 
because myofibroblasts are scar-forming cells that drive 
the overproduction of extracellular matrix (ECM) proteins 
associated with scarring [111]. Consistent with this, Xing 
and colleagues found that ucMSC-EXO appeared to 
promote repair of mouse wounds, with a reduction in 
scarring [112]. This was attributed to the ability of uMSC-
EXO to prevent TGF-β-dependent transdifferentiation of 
fibroblasts into myofibroblasts. Crucially, using RNAseq, 
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Importantly, the reduced the expression of TGF-β1, 
SMAD2, α-SMA and collagen 1 in the healing tissue, 
with TGF-β1 expression also blunted in cultured HDFs 
[127]. These effects were tentatively attributed to miR-
425-5p and miR-142-3p because these miRNAs were 
elevated in EXOs and repressed TGF-β1 expression 
HDFs [127]. However, further studies are required to 
determine whether these miRNAs abrogate TGF-β1-
dependent differentiation of fibroblasts to myofibroblasts. 
Nonetheless, when combined with earlier observations 
on the ability of miR-21-5p to abrogate TGF-β1 signalling 
(see ucMSC-EXO section above), it seems that any 
miRNA that dampens the TGF-β1 pathway in HDFs 
may prevent fibroblast differentiation to myofibroblast 
to thus limit scarring. However, comparisons of the 
relative efficacy with which unrelated miRNAs can block 
myofibroblast activation during wound repair have not 
been reported to our knowledge. 
CONCLUSION
With such a plethora of EXO sources, which also 
include endothelial progenitor cells [128, 129], it is clear 
that there is a need for standardisation of methods for 
purification and physico-chemical characterisation of 
EXOs [130]. Furthermore, studies that characterise and 
compare the exosomal miRNA profiles of the different 
cell types whose EXOs can repair wounded skin are 
required in order to establish which miRNA functions are 
most consistently associated with wound healing EXOs. 
It is not known at present if EXOs from adipose, bone 
marrow, amniotic, umbilical and epithelial sources are 
equally effective at targeting keratinocytes, fibroblasts, 
macrophages and endothelial cells, respectively, to 
modulate wound healing. Hence, there is also a need to 
determine the relative levels of EXOs uptake by different 
recipient cells in the skin, and define the underlying 
mechanisms associated with each recipient cell type. 
In addition, the stability of EXOs and their cargoes should 
be studied under real-world conditions that would be 
associated with their translational deployment in clinical 
settings. Some authors point out that stem cells may 
contribute to tumour formation, thrombosis, and adverse 
immune responses, using such arguments to justify the 
therapeutic potential of EXOs [113, 125]. However, there 
is a long history of safe stem cell transplantation in the 
context of haematological malignancies [126] and adult 
MSCs appear to be safe [127]. Hence the use of MSC-
derived exosomes rather than MSCs in wound healing 
may ultimately depend on pragmatic considerations 
such as the fact that they can be freeze-dried or spray-
dried for deployment in cold supply chains at 4°C, which 
is not feasible for cells [131, 132].   
Finally, although some studies have examined the 
wound healing potential of exosomal miRNA in diabetic 
rodent models, translational exploitation of these 
approaches will benefit from further studies using human 
wounded skin models. Human skin organoids used by 
Keswani, Feinberg and co-workers [32, 133] and ex vivo 
human skin deployed by Landén and colleagues [134] 
will enable deeper insight into the translational potential 
EPITHELIAL STEM CELL-DERIVED EXOSOMES
Epidermal Keratinocyte Microvesicles and 
Exosomes: miR-21-5p
Comparative analysis of miRNA profiles from 
keratinocyte EXOs, MVs and ABs defined a cohort of 
437 miRNAs that were shared by all three EVs [118]. 
Few of these have been studied specifically in relation 
to intercellular communication during wound healing. 
However, recent work by Bi and co-workers showed 
that, upon lentiviral overexpression in primary human 
keratinocytes, miR-21-5p partitions into MVs that 
promoted wound closure in diabetic rats [115]. Studies 
on cultured cells indicated the pro-healing effects of the 
miR-21-5p-laden MVs was associated with enhanced 
angiogenesis, fibroblast migration and, importantly, 
fibroblast differentiation into myofibroblasts [115]. 
Furthermore, work by Roy and colleagues showed 
that miR-21-5p from keratinocyte EXOs promotes 
the differentiation of inflammatory macrophages to 
fibroblast-like cells during wound repair [119]. This 
transdifferentiation of macrophages into fibroblast-like 
cells is thought to play an important role in the resolution 
of inflammation during wound repair and blockade 
of miRNA loading into EXOs impaired the resolution 
of wound inflammation by promoting the persistence 
of wound macrophages [119, 120]. Interestingly, 
macrophages have recently been shown to undergo 
a process of transdifferentiation into myofibroblasts 
in kidney and macular fibrosis [121-124]. Although 
macrophage-myofibroblast transition (MMT) has not been 
established in skin wounds, it is plausible that miR-21-5p 
functions first to support the transition of macrophages to 
fibroblast-like cells and then to promote differentiation of 
the fibroblast-like cells into myofibroblasts. This model is 
consistent with the observations demonstrating a role for 
miR-21-5p in fibroblast differentiation into myofibroblasts 
[114, 115]. Since, however, myofibroblasts drive the 
ECM production associated with scarring, it seems 
miR-21-5p has a complex pathophysiological role in 
wound healing, promoting wound repair on the one and 
driving myofibroblast activation on the other. This calls 
for careful comparison of miR-21-5p concentrations 
and spatiotemporal dynamics of miR-21-5p in scar 
versus scar-free wound healing, particularly in terms of 
how miR-21-5p levels affect the fine balancing act that 
myofibroblasts perform in mediating wound contraction 
on the one hand without excessive scarring on the other 
[125, 126].
Epidermal Stem Cell Exosomes: miR-425-5p and 
miR-142-3p
Beyond miR-21-5p, there is evidence for other 
keratinocyte-derived EXOs in the promotion of wound 
repair. Zhang and co-workers observed very recently 
that wound closure in rat skin was accelerated by EXOs 
reportedly from epidermal stem cells [127]. Levels of 
scarring were apparently reduced in the EXO-treated 
wound compared to EGF or PBS-treated controls, 
and wound repair was associated with increased 
angiogenesis and innervation in the wound bed [127]. 
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S., Herter, E. K., Wang, Y., Ma, Y., Ehrstrom, M., 
Eidsmo, L., Kasper, M., Pivarcsi, A., Sonkoly, E., 
Catrina, S. B., Stahle, M. and Xu Landen, N. (2017) 
MicroRNA-132 with Therapeutic Potential in Chronic 
Wounds. J Invest Dermatol. 137, 2630-2638
16. Shi, J., Ma, X., Su, Y., Song, Y., Tian, Y., Yuan, S., 
Zhang, X., Yang, D., Zhang, H., Shuai, J., Cui, W., 
Ren, F., Plikus, M. V., Chen, Y., Luo, J. and Yu, Z. 
(2018) MiR-31 Mediates Inflammatory Signaling to 
Promote Re-Epithelialization during Skin Wound 
Healing. J Invest Dermatol. 138, 2253-2263
17. Wang, W., Yang, C., Wang, X. Y., Zhou, L. Y., Lao, 
G. J., Liu, D., Wang, C., Hu, M. D., Zeng, T. T., Yan, 
L. and Ren, M. (2018) MicroRNA-129 and -335 
Promote Diabetic Wound Healing by Inhibiting Sp1-
Mediated MMP-9 Expression. Diabetes. 67, 1627-
1638
18. Zhang, W., Yi, X., An, Y., Guo, S., Li, S., Song, 
P., Chang, Y., Zhang, S., Gao, T., Wang, G. and 
Li, C. (2018) MicroRNA-17-92 cluster promotes 
the proliferation and the chemokine production of 
keratinocytes: implication for the pathogenesis of 
psoriasis. Cell death & disease. 9, 567
19. Simoes, A., Chen, L., Chen, Z., Zhao, Y., Gao, S., 
Marucha, P. T., Dai, Y., DiPietro, L. A. and Zhou, X. 
(2019) Differential microRNA profile underlies the 
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wounds. Scientific reports. 9, 7160
of exosomal miRNAs for diabetic wound healing, 
especially when combined with high glucose, reactive 
oxygen species (ROS) generators and advanced 
glycation end products [135, 136]. Studies on rodents 
can in turn be designed mainly for evaluation of safety 
and biodistribution.
In summary, the evidence from the last decade has 
revealed that exosomal miRNAs from diverse cell types 
can target diverse pathways to promote cutaneous 
wound healing. However, our understanding of the 
exosomal miRNA signatures across various cells from 
which EXO have been obtained using standardised 
conditions is limited and the relative levels of EXO uptake 
by skin, immune and endothelial cells warrant further 
investigation, along with the mechanisms of uptake under 
conditions that mimic the diabetic microenvironment.
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